NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR

    NEXT STORY
    Point-of-Care (POC) Testing Market by Product, End-user and Country – Global Forecast to 2025
    PREV STORY
    Adaptive Biotechnologies Announces Pricing of Initial Public Offering
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Achaogen Reports First Quarter 2016 Financial Results

    -- Accelerated Timeline for Reporting Top-Line Results from Phase 3 EPIC Registration Clinical Trial ...

    author_avatar
    NASDAQ Market News

    Intra-Cellular Therapies Presents Additional Efficacy and Safety Data From the Positive Phase 3 Clinical Trial of ITI-007 for the Treatment of Schizophrenia and From the Positron Emission Tomography Study

    NEW YORK, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Terveystalo Plc: The Finnish Competition and Consumer Authority applies for an extension for investigating the transaction between Terveystalo and Attendo

    Terveystalo Plc Stock Exchange release 5 October 2018 at 09:00 a.m EEST Terveystalo Plc ...

    author_avatar
    NASDAQ Market News